Literature DB >> 31502199

A Stroll Down the CerS Lane.

Iris D Zelnik1, Batsheva Rozman1, Eden Rosenfeld-Gur1, Shifra Ben-Dor2, Anthony H Futerman3.   

Abstract

The majority of enzymes in the sphingolipid (SL) biosynthetic pathway have been identified over the past couple of decades. Despite significant work, and despite their crucial and central roles in SL synthesis, significant information is still lacking concerning the enzymes that catalyze the N-acylation of sphingoid long chain bases, namely the ceramide synthases (CerS), a family of six mammalian genes originally named longevity assurance (Lass) genes. Each of these six endoplasmic reticulum (ER) membrane-bound enzymes utilizes a relatively restricted sub-set of fatty acyl-CoAs for N-acylation, but are far more promiscuous about the use of long chain bases. The reason that mammals and other species have multiple CerS, generating a specific subset of ceramides, is not yet known, but implies an important role for ceramides containing specific fatty acids in cell physiology. In this brief chapter, we will stroll down the CerS lane and discuss what is known, and what is not known, about this important enzyme family.

Entities:  

Keywords:  Ceramide; Ceramide synthase; N-acyl transferase; N-acylation; Sphingolipids

Mesh:

Substances:

Year:  2019        PMID: 31502199     DOI: 10.1007/978-3-030-21162-2_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

Review 1.  Reign in the membrane: How common lipids govern mitochondrial function.

Authors:  Katsuhiko Funai; Scott A Summers; Jared Rutter
Journal:  Curr Opin Cell Biol       Date:  2020-02-24       Impact factor: 8.382

2.  Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease.

Authors:  Annelise M Poss; J Alan Maschek; James E Cox; Benedikt J Hauner; Paul N Hopkins; Steven C Hunt; William L Holland; Scott A Summers; Mary C Playdon
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

3.  Different rates of flux through the biosynthetic pathway for long-chain versus very-long-chain sphingolipids.

Authors:  Iris D Zelnik; Giora Volpert; Leena E Viiri; Dimple Kauhanen; Tamar Arazi; Katriina Aalto-Setälä; Reijo Laaksonen; Anthony H Futerman
Journal:  J Lipid Res       Date:  2020-07-10       Impact factor: 5.922

Review 4.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Sphingolipids in embryonic development, cell cycle regulation, and stemness - Implications for polyploidy in tumors.

Authors:  Christina Voelkel-Johnson
Journal:  Semin Cancer Biol       Date:  2021-01-08       Impact factor: 17.012

Review 6.  Ceramides and other sphingolipids as drivers of cardiovascular disease.

Authors:  Ran Hee Choi; Sean M Tatum; J David Symons; Scott A Summers; William L Holland
Journal:  Nat Rev Cardiol       Date:  2021-03-26       Impact factor: 49.421

Review 7.  Adipocyte Ceramides-The Nexus of Inflammation and Metabolic Disease.

Authors:  Bhagirath Chaurasia; Chad Lamar Talbot; Scott A Summers
Journal:  Front Immunol       Date:  2020-09-23       Impact factor: 7.561

Review 8.  Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease.

Authors:  Rebekah J Nicholson; Marcus G Pezzolesi; Scott A Summers
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

Review 9.  Ceramides in Metabolism: Key Lipotoxic Players.

Authors:  Bhagirath Chaurasia; Scott A Summers
Journal:  Annu Rev Physiol       Date:  2020-11-06       Impact factor: 19.318

10.  Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.

Authors:  Keri Barron; Besim Ogretmen; Natalia Krupenko
Journal:  J Nutr Biochem       Date:  2021-08-04       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.